SCHEMBL1460583

SCHEMBL1460583

Nc1cncn1Cc1cccc(F)c1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 4/20 0.51
CYP11B2 P19099 4/20 0.51
L3MBTL1 Q9Y468 1/20 0.50
DBH P09172 1/20 0.46
CDK9 P50750 1/20 0.45
ALDH1A1 P00352 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
IDO1 P14902 1/20 0.44
DPP4 P27487 1/20 0.43
SLC2A1 P11166 1/20 0.43
TAAR1 Q96RJ0 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
ROCK2 O75116 1/20 0.41
ROCK1 Q13464 1/20 0.41
HPGDS O60760 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32683807 0.80 CYP11B1 (0.59) CYP11B1CYP11B2DBHIDO1SLC2A1
SCHEMBL15358325 0.76 IDO1 (0.57) CYP11B1CYP11B2CDK9IDO1HPGDS
SCHEMBL10644152 0.72 L3MBTL1 (0.50) CYP11B1CYP11B2L3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL1460580 0.70 ALDH1A1 (0.58) CYP11B1CYP11B2L3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL4179745 0.69 CYP11B1 (0.65) CYP11B1CYP11B2L3MBTL1DBHALDH1A1
SCHEMBL11015789 0.69 ADORA2A (0.71)
SCHEMBL21121839 0.69 L3MBTL1 (0.44) CYP11B1CYP11B2L3MBTL1DBHCDK9
SCHEMBL7974168 0.69 CDK9 (0.45) CYP11B1CYP11B2L3MBTL1CDK9ALDH1A1
SCHEMBL3616273 0.69 MAPT (0.65) CYP11B1CYP11B2L3MBTL1ALDH1A1MEN1
SCHEMBL10721034 0.69 CYP11B1 (0.48) CYP11B1CYP11B2L3MBTL1DBHALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2473509-A1 KINASE INHIBITORS, PRODRUG FORMS THEREOF AND THEIR USE IN THERAPY Auckland UniServices Limited (NZ) 2012-07-11 EP disclosed
WO-2011028135-A1 KINASE INHIBITORS, PRODRUG FORMS THEREOF AND THEIR USE IN THERAPY AUCKLAND UNISERVICES LIMITED (NZ) 2011-03-10 WO disclosed